Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: Surgical end points from national surgical adjuvant breast and bowel project trial R-04

Journal of Clinical Oncology

Volumn 32, Issue 18, 2014, Pages 1927-1934

  O'Connell, Michael J ^a   Colangelo, Linda H ^a   Beart, Robert W ^a,d   Petrelli, Nicholas J ^a,f   Allegra, Carmen J ^a,g   Sharif, Saima ^a   Pitot, Henry C ^a,j   Shields, Anthony F ^a,k   Landry, Jerome C ^m   Ryan, David P ⁿ   Parda, David S ^a,b   Mohiuddin, Mohammed ^a,u   Arora, Amit ^a,e   Evans, Lisa S ^a,o   Bahary, Nathan ^a,c   Soori, Gamini S ^a,p   Eakle, Janice ^a,h   Robertson, John M ^a,l   Moore Jr , Dennis F ^a,q   Mullane, Michael R ^a,r   Marchello, Benjamin T ^a,s   Ward, Patrick J ^a,t   Wozniak, Timothy F ^a,f   Roh, Mark S ^a,i   Yothers, Greg ^a   Wolmark, Norman ^a,b   more..

^a NSABP Foundation Inc   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d Colorectal Surgery Institute Glendale Memorial Hospital ^*  (United States)

^e KAISER PERMANENTE   (United States)

^f HELEN F GRAHAM CANCER CENTER   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h Florida Cancer Specialists   (United States)

ⁱ M D ANDERSON CANCER CENTER ORLANDO   (United States)

^j MAYO CLINIC   (United States)

^k KARMANOS CANCER INSTITUTE   (United States)

^l Beaumont Hospital System   (United States)

^m EMORY UNIVERSITY   (United States)

ⁿ MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^o FORSYTH MEDICAL CENTER   (United States)

^p MISSOURI VALLEY CANCER CONSORTIUM   (United States)

^q Via Christi Rehabilitation Center   (United States)

^r Jr Hospital of Cook County   (United States)

^s Montana Cancer Consortium   (United States)

^t Oncology Hematology Care   (United States)

^u KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; OXALIPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; PLATINUM COMPLEX;

ADULT; ANUS SURGERY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; SPHINCTER SPARING SURGERY; TREATMENT DURATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; ANAL CANAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RECTUM TUMOR; TREATMENT OUTCOME;

ADULT; AGED; ANAL CANAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84905457749     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.53.7753     Document Type: Article

References (28)

1. Gunderson LL, Sargent DJ, Tepper JE, et al: Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis. J Clin Oncol 22:1785-1796, 2004 (Pubitemid 41095168)
2. Gunderson LL, Jessup JM, Sargent DJ, et al: Revised tumor and node categorization for rectal cancer based on Surveillance, Epidemiology, and End Results and rectal pooled analysis outcomes. J Clin Oncol 28:256-263, 2010
3. Gastrointestinal Tumor Study Group: Prolongation of the disease-free interval in surgically treated rectal carcinoma: Gastrointestinal Tumor Study Group. N Engl J Med 312:1465-1472, 1985
4. Krook JE, Moertel CG, Gunderson LL, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 1991
5. Wolmark N, Wieand HS, Hyams DM, et al: Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92:388-396, 2000 (Pubitemid 30154820)
6. O'Connell MJ, Martenson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994
7. Van Cutsem E, Twelves C, Cassidy J, et al: Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study. J Clin Oncol 19:4097-4106, 2001 (Pubitemid 33049527)
8. Mayer RJ: Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer? J Clin Oncol 25:4165-4167, 2007
9. Dunst J, Reese T, Sutter T, et al: Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 20:3983-3991, 2002
10. Miwa M, Ura M, Nishida M, et al: Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectivity in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34:1274-1281, 1998 (Pubitemid 28342121)
11. Rothenberg ML, Oza AM, Bigelow RH, et al: Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial. J Clin Oncol 21:2059-2069, 2003 (Pubitemid 46606353)
12. André T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004 (Pubitemid 38702845)
13. Kuebler JP, Wieand HS, O'Connell MJ, et al: Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07. J Clin Oncol 25:2198-2204, 2007 (Pubitemid 46954643)
14. Cividalli A, Ceciarelli F, Livdi E, et al: Radiosensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule. Int J Radiat Oncol Biol Phys 52:1092-1098, 2002 (Pubitemid 34219031)
15. Frykholm GJ, Glimelius B, Påhlman L: Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36:564-572, 1993 (Pubitemid 23177416)
16. Gerard JP: The use of radiotherapy for patients with low rectal cancer: An overview of the Lyon experience. Aust N Z J Surg 64:457-463, 1994
17. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
18. White SJ, Freedman LS: Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer 37:849-857, 1978 (Pubitemid 8344907)
19. Wang YH: Fiduciary intervals: What are they? Am Stat 54:105-111, 2000
20. Das P, Lin EH, Bhatia S, et al: Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis. Int J Radiat Oncol Biol Phys 66:1378-1383, 2006
21. Ramani VS, Sun Myint A, Montazeri A, et al: Preoperative chemoradiotherapy for rectal cancer: A comparison between intravenous 5-fluorouracil and oral capecitabine. Colorectal Dis 12:37-46, 2010 (suppl 2)
22. Aschele C, Cionini L, Lonardi S, et al: Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 29:2773-2780, 2011
23. Gérard JP, Azria D, Gourgou-Bourgade S, et al: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638-1644, 2010
24. Gérard JP, Azria D, Gourgou-Bourgade S, et al: Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol 30:4558-4565, 2012
25. Schmoll H-J, Haustermans K, Price TJ, et al: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial. J Clin Oncol 31:212s, 2013 (suppl; abstr 3531)
26. Cancer Genome Atlas Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337, 2012
27. Ganz PA, Lopa SH, Yothers G, et al: Comparative effectiveness of sphincter-sparing surgery (SSS) vs. abdomino-perineal resection (APR) in rectal cancer: Patient reported outcomes (PROs) from NSABP R-04. J Clin Oncol 30:214s, 2012 (suppl 15s; abstr 3545)
28. Yothers G, Ganz PA, Lopa SH, et al: Patient reported outcomes (PROs) comparison of 5-FU and capecitabine (cape) with concurrent radiotherapy (RT) for neoadjuvant treatment of rectal cancer: Results of NSABP R-04. J Clin Oncol 30, 2012 (suppl 9; abstr 391)